Peringatan Keamanan

The oral LD50 is 2.96 mg/kg in the mouse. Symptoms of overdose include nausea, vomiting, abdominal cramps, diarrhea, urinary incontinence, salivation, sweating, difficulty in breathing, bradycardia, or cardiac irregularities.

Demecarium

DB00944

small molecule approved

Deskripsi

Demecarium is an indirect-acting parasympathomimetic agent that is used to treat glaucoma. It is a cholinesterase inhibitor or an anticholinesterase. Cholinesterase inhibitors prolong the effect of acetylcholine, which is released at the neuroeffector junction of parasympathetic postganglion nerves, by inactivating the cholinesterases that break it down. Demecarium inactivates both pseudocholinesterase and acetylcholinesterase. In the eye, this causes constriction of the iris sphincter muscle (causing miosis) and the ciliary muscle. The outflow of the aqueous humor is facilitated, which leads to a reduction in intraocular pressure.

Struktur Molekul 2D

Berat 556.7797
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

292 Data
Dipyridamole The therapeutic efficacy of Demecarium can be decreased when used in combination with Dipyridamole.
Ephedrine Demecarium may increase the neuromuscular blocking activities of Ephedrine.
Bambuterol Demecarium may increase the neuromuscular blocking activities of Bambuterol.
Clevidipine Demecarium may increase the neuromuscular blocking activities of Clevidipine.
Sar9, Met (O2)11-Substance P Demecarium may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.
Mirabegron Demecarium may increase the neuromuscular blocking activities of Mirabegron.
Moxisylyte Demecarium may increase the neuromuscular blocking activities of Moxisylyte.
Propacetamol Demecarium may increase the neuromuscular blocking activities of Propacetamol.
Procaine Demecarium may increase the neuromuscular blocking activities of Procaine.
Cocaine Demecarium may increase the neuromuscular blocking activities of Cocaine.
Trimethaphan Demecarium may increase the neuromuscular blocking activities of Trimethaphan.
Doxacurium Demecarium may increase the neuromuscular blocking activities of Doxacurium.
Chloroprocaine Demecarium may increase the neuromuscular blocking activities of Chloroprocaine.
Tubocurarine Demecarium may increase the neuromuscular blocking activities of Tubocurarine.
Aclidinium Demecarium may increase the neuromuscular blocking activities of Aclidinium.
Butyrylthiocholine Demecarium may increase the neuromuscular blocking activities of Butyrylthiocholine.
Oxybuprocaine Demecarium may increase the neuromuscular blocking activities of Oxybuprocaine.
Benzonatate Demecarium may increase the neuromuscular blocking activities of Benzonatate.
Succinylcholine The metabolism of Succinylcholine can be decreased when combined with Demecarium.
Tramadol The therapeutic efficacy of Tramadol can be decreased when used in combination with Demecarium.
Trospium The therapeutic efficacy of Trospium can be decreased when used in combination with Demecarium.
Oxyphenonium The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Demecarium.
Butabarbital The therapeutic efficacy of Butabarbital can be decreased when used in combination with Demecarium.
Butalbital The therapeutic efficacy of Butalbital can be decreased when used in combination with Demecarium.
Benzatropine The therapeutic efficacy of Benzatropine can be decreased when used in combination with Demecarium.
Ziprasidone The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Demecarium.
Disopyramide The therapeutic efficacy of Disopyramide can be decreased when used in combination with Demecarium.
Talbutal The therapeutic efficacy of Talbutal can be decreased when used in combination with Demecarium.
Pentobarbital The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Demecarium.
Amitriptyline The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Demecarium.
Ipratropium The therapeutic efficacy of Ipratropium can be decreased when used in combination with Demecarium.
Methadone The therapeutic efficacy of Methadone can be decreased when used in combination with Demecarium.
Olanzapine The therapeutic efficacy of Olanzapine can be decreased when used in combination with Demecarium.
Metixene The therapeutic efficacy of Metixene can be decreased when used in combination with Demecarium.
Terfenadine The therapeutic efficacy of Terfenadine can be decreased when used in combination with Demecarium.
Buclizine The therapeutic efficacy of Buclizine can be decreased when used in combination with Demecarium.
Clozapine The therapeutic efficacy of Clozapine can be decreased when used in combination with Demecarium.
Doxylamine The therapeutic efficacy of Doxylamine can be decreased when used in combination with Demecarium.
Trihexyphenidyl The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Demecarium.
Oxyphencyclimine The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Demecarium.
Procyclidine The therapeutic efficacy of Procyclidine can be decreased when used in combination with Demecarium.
Profenamine The therapeutic efficacy of Profenamine can be decreased when used in combination with Demecarium.
Secobarbital The therapeutic efficacy of Secobarbital can be decreased when used in combination with Demecarium.
Promazine The therapeutic efficacy of Promazine can be decreased when used in combination with Demecarium.
Hyoscyamine The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Demecarium.
Cyproheptadine The therapeutic efficacy of Cyproheptadine can be decreased when used in combination with Demecarium.
Imipramine The therapeutic efficacy of Imipramine can be decreased when used in combination with Demecarium.
Methscopolamine bromide The therapeutic efficacy of Methscopolamine bromide can be decreased when used in combination with Demecarium.
Metharbital The therapeutic efficacy of Metharbital can be decreased when used in combination with Demecarium.
Fluoxetine The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Demecarium.
Chlorpromazine The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Demecarium.
Darifenacin The therapeutic efficacy of Darifenacin can be decreased when used in combination with Demecarium.
Tridihexethyl The therapeutic efficacy of Tridihexethyl can be decreased when used in combination with Demecarium.
Triflupromazine The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Demecarium.
Dextromethorphan The therapeutic efficacy of Dextromethorphan can be decreased when used in combination with Demecarium.
Anisotropine methylbromide The therapeutic efficacy of Anisotropine methylbromide can be decreased when used in combination with Demecarium.
Nortriptyline The therapeutic efficacy of Nortriptyline can be decreased when used in combination with Demecarium.
Amoxapine The therapeutic efficacy of Amoxapine can be decreased when used in combination with Demecarium.
Atropine The therapeutic efficacy of Atropine can be decreased when used in combination with Demecarium.
Thiopental The therapeutic efficacy of Thiopental can be decreased when used in combination with Demecarium.
Nicardipine The therapeutic efficacy of Nicardipine can be decreased when used in combination with Demecarium.
Mecamylamine The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Demecarium.
Pirenzepine The therapeutic efficacy of Pirenzepine can be decreased when used in combination with Demecarium.
Paroxetine The therapeutic efficacy of Paroxetine can be decreased when used in combination with Demecarium.
Homatropine methylbromide The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Demecarium.
Scopolamine The therapeutic efficacy of Scopolamine can be decreased when used in combination with Demecarium.
Isoflurane The therapeutic efficacy of Isoflurane can be decreased when used in combination with Demecarium.
Benzquinamide The therapeutic efficacy of Benzquinamide can be decreased when used in combination with Demecarium.
Clidinium The therapeutic efficacy of Clidinium can be decreased when used in combination with Demecarium.
Propiomazine The therapeutic efficacy of Propiomazine can be decreased when used in combination with Demecarium.
Propantheline The therapeutic efficacy of Propantheline can be decreased when used in combination with Demecarium.
Primidone The therapeutic efficacy of Primidone can be decreased when used in combination with Demecarium.
Dicyclomine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Demecarium.
Biperiden The therapeutic efficacy of Biperiden can be decreased when used in combination with Demecarium.
Brompheniramine The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Demecarium.
Methylphenobarbital The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Demecarium.
Quinidine The therapeutic efficacy of Quinidine can be decreased when used in combination with Demecarium.
Amantadine The therapeutic efficacy of Amantadine can be decreased when used in combination with Demecarium.
Maprotiline The therapeutic efficacy of Maprotiline can be decreased when used in combination with Demecarium.
Methantheline The therapeutic efficacy of Methantheline can be decreased when used in combination with Demecarium.
Hexafluronium The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Demecarium.
Cycrimine The therapeutic efficacy of Cycrimine can be decreased when used in combination with Demecarium.
Desloratadine The therapeutic efficacy of Desloratadine can be decreased when used in combination with Demecarium.
Glycopyrronium The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Demecarium.
Tolterodine The therapeutic efficacy of Tolterodine can be decreased when used in combination with Demecarium.
Oxybutynin The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Demecarium.
Promethazine The therapeutic efficacy of Promethazine can be decreased when used in combination with Demecarium.
Diphenhydramine The therapeutic efficacy of Diphenhydramine can be decreased when used in combination with Demecarium.
Pentolinium The therapeutic efficacy of Pentolinium can be decreased when used in combination with Demecarium.
Doxepin The therapeutic efficacy of Doxepin can be decreased when used in combination with Demecarium.
Flavoxate The therapeutic efficacy of Flavoxate can be decreased when used in combination with Demecarium.
Desipramine The therapeutic efficacy of Desipramine can be decreased when used in combination with Demecarium.
Orphenadrine The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Demecarium.
Phenobarbital The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Demecarium.
Escitalopram The therapeutic efficacy of Escitalopram can be decreased when used in combination with Demecarium.
Quetiapine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Demecarium.
Levacetylmethadol The therapeutic efficacy of Levacetylmethadol can be decreased when used in combination with Demecarium.
Diphenidol The therapeutic efficacy of Diphenidol can be decreased when used in combination with Demecarium.
Aripiprazole The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Demecarium.
Chlorprothixene The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Demecarium.

Target Protein

Acetylcholinesterase ACHE
Cholinesterase BCHE

Referensi & Sumber

Synthesis reference: Schrnid, O.; US. Patent 2,789,981; April 23, 1957; assigned to Oesterreichische Stickstoffwerke AG, Austria.
Artikel (PubMed)
  • PMID: 12641839
    Ward DA, Abney K, Oliver JW: The effects of topical ocular application of 0.25% demecarium bromide on serum acetylcholinesterase levels in normal dogs. Vet Ophthalmol. 2003 Mar;6(1):23-5.
  • PMID: 7887518
    Krohne SG: Effect of topically applied 2% pilocarpine and 0.25% demecarium bromide on blood-aqueous barrier permeability in dogs. Am J Vet Res. 1994 Dec;55(12):1729-33.
  • PMID: 8430939
    Gum GG, Gelatt KN, Gelatt JK, Jones R: Effect of topically applied demecarium bromide and echothiophate iodide on intraocular pressure and pupil size in beagles with normotensive eyes and beagles with inherited glaucoma. Am J Vet Res. 1993 Feb;54(2):287-93.

Contoh Produk & Brand

Produk: 0 • International brands: 3
International Brands
  • Humorsol — MSD
  • Tonilen
  • Tosmilen

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul